Zheng Y[au] - Search Results

Year	Number of Results
1979	6
1980	1
1981	7
1982	7
1983	2
1984	10
1985	10
1986	15
1987	11
1988	14
1989	22
1990	19
1991	31
1992	31
1993	46
1994	39
1995	47
1996	49
1997	56
1998	87
1999	78
2000	102
2001	127
2002	158
2003	202
2004	264
2005	337
2006	351
2007	441
2008	548
2009	683
2010	784
2011	980
2012	1216
2013	1344
2014	1534
2015	1643
2016	1837
2017	2037
2018	2259
2019	2639
2020	3250
2021	3845
2022	2178
2023	5

1

LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer.

Shen DD, Pang JR, Bi YP, Zhao LF, Li YR, Zhao LJ, Gao Y, Wang B, Wang N, Wei L, Guo H, Liu HM, Zheng YC. Shen DD, et al. Among authors: zheng yc. Mol Cancer. 2022 Mar 16;21(1):75. doi: 10.1186/s12943-022-01557-1. Mol Cancer. 2022. PMID: 35296335 Free PMC article.

2

Evidence-based biomaterials research.

Zhang K, Ma B, Hu K, Yuan B, Sun X, Song X, Tang Z, Lin H, Zhu X, Zheng Y, J García A, G Mikos A, M Anderson J, Zhang X. Zhang K, et al. Among authors: zheng y. Bioact Mater. 2022 Apr 25;15:495-503. doi: 10.1016/j.bioactmat.2022.04.014. eCollection 2022 Sep. Bioact Mater. 2022. PMID: 35633843 Free PMC article.

3

Retraction Note: Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.

Wu DM, Zheng ZH, Zhang YB, Fan SH, Zhang ZF, Wang YJ, Zheng YL, Lu J. Wu DM, et al. Among authors: zheng yl. J Exp Clin Cancer Res. 2022 Apr 1;41(1):121. doi: 10.1186/s13046-022-02347-9. J Exp Clin Cancer Res. 2022. PMID: 35365213 Free PMC article. No abstract available.

4

Enhancing Single-Molecule Fluorescence Spectroscopy with Simple and Robust Hybrid Nanoapertures.

Kotnala A, Ding H, Zheng Y. Kotnala A, et al. Among authors: zheng y. ACS Photonics. 2021 Jun 16;8(6):1673-1682. doi: 10.1021/acsphotonics.1c00045. Epub 2021 May 18. ACS Photonics. 2021. PMID: 35445142 Free PMC article.

5

Detailed resume of RNA m⁶A demethylases.

Shen D, Wang B, Gao Y, Zhao L, Bi Y, Zhang J, Wang N, Kang H, Pang J, Liu Y, Pang L, Chen ZS, Zheng YC, Liu HM. Shen D, et al. Among authors: zheng yc. Acta Pharm Sin B. 2022 May;12(5):2193-2205. doi: 10.1016/j.apsb.2022.01.003. Epub 2022 Jan 11. Acta Pharm Sin B. 2022. PMID: 35646549 Free PMC article. Review.

6

Pathogenesis and treatment of multiple myeloma.

Yang P, Qu Y, Wang M, Chu B, Chen W, Zheng Y, Niu T, Qian Z. Yang P, et al. Among authors: zheng y. MedComm (2020). 2022 Jun 2;3(2):e146. doi: 10.1002/mco2.146. eCollection 2022 Jun. MedComm (2020). 2022. PMID: 35665368 Free PMC article. Review.

7

Opto-Thermocapillary Nanomotors on Solid Substrates.

Li J, Kollipara PS, Liu Y, Yao K, Liu Y, Zheng Y. Li J, et al. Among authors: zheng y. ACS Nano. 2022 May 20. doi: 10.1021/acsnano.1c09800. Online ahead of print. ACS Nano. 2022. PMID: 35594375

8

Quantifying Wetting Dynamics with Triboelectrification.

Zhang X, Scaraggi M, Zheng Y, Li X, Wu Y, Wang D, Dini D, Zhou F. Zhang X, et al. Among authors: zheng y. Adv Sci (Weinh). 2022 Jun 8:e2200822. doi: 10.1002/advs.202200822. Online ahead of print. Adv Sci (Weinh). 2022. PMID: 35674345

9

[Programmed Necrosis Inducers for Cancer Treatment].

Zhao Q, Yang LJ, Zheng YB, Gong JH. Zhao Q, et al. Among authors: zheng yb. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022 Apr;44(2):338-347. doi: 10.3881/j.issn.1000-503X.13241. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022. PMID: 35538772 Free article. Chinese.

10

Anti-inflammatory sesquiterpenoid dimers from Artemisia atrovirens.

Shao Z, Li L, Zheng Y, Gong Q, Ke CQ, Yao S, Zhang H, Tang C, Ye Y. Shao Z, et al. Among authors: zheng y. Fitoterapia. 2022 Jun;159:105199. doi: 10.1016/j.fitote.2022.105199. Epub 2022 Apr 20. Fitoterapia. 2022. PMID: 35452745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results